TNFSF10 and cancer: However, EVs from TRAIL-expressing mesenchymal stem cells overcome these limitations, eliciting dose-dependent apoptosis in multiple cancer cell types in vivo, including pronounced apoptosis in TRAIL-resistant cancer cells (149).